๐ Incidence & definition
~60% at โค28 wk. NICHD 2018: mild (room air), moderate (<30% O2), severe (โฅ30% O2 or PPV) at 36 wk PMA. Grade III(A) for lethal BPD.
๐งฌ Pathophysiology (new BPD)
Arrested alveolarization + dysregulated microvascular development. Inflammation, volutrauma, oxygen toxicity, PDA, infection.
๐ก๏ธ Prevention strategies
Early CPAP, INSURE/LISA, caffeine, gentle ventilation (volume-targeted), avoid hyperoxia, treat PDA, optimal nutrition.
๐ Treatment (supportive)
Diuretics (furosemide, chlorothiazide) for pulmonary edema. Bronchodilators (albuterol) for airway reactivity. Pulmonary hypertension therapy (iNO, sildenafil).
โ ๏ธ Systemic corticosteroids
Dexamethasone improves extubation but increases CP risk; reserve for severe ventilator-dependent infants after 7-14 days with high BPD risk.
๐ Prognosis
BPD โ neurodevelopmental impairment, asthma-like symptoms, pulmonary hypertension, rehospitalizations. Lung function improves slowly over childhood.